Hodges Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.92M Sell
8,613
-42
-0.5% -$42.6K 0.66% 55
2025
Q4
$9.3M Sell
8,655
-2,980
-26% -$2.85M 0.8% 39
2025
Q3
$8.88M Buy
11,635
+800
+7% +$595K 0.76% 40
2025
Q2
$8.45M Buy
10,835
+664
+7% +$516K 0.81% 42
2025
Q1
$8.4M Sell
10,171
-755
-7% -$628K 0.84% 39
2024
Q4
$8.43M Buy
10,926
+4,248
+64% +$3.52M 0.51% 66
2024
Q3
$5.92M Sell
6,678
-930
-12% -$836K 0.38% 80
2024
Q2
$6.89M Buy
7,608
+378
+5% +$302K 0.46% 68
2024
Q1
$5.62M Sell
7,230
-1,075
-13% -$765K 0.36% 81
2023
Q4
$4.84M Buy
8,305
+713
+9% +$416K 0.26% 105
2023
Q3
$4.08M Buy
+7,592
New +$3.91M 0.48% 62
2023
Q2
Sell
-11,158
Closed -$4.68M 104
2023
Q1
$2.85M Buy
11,158
+3,512
+46% +$1.18M 0.23% 109
2022
Q4
$2.8M Buy
7,646
+959
+14% +$340K 0.24% 104
2022
Q3
$2.16M Buy
6,687
+1,563
+31% +$495K 0.36% 77
2022
Q2
$1.66M Sell
5,124
-9,224
-64% -$2.77M 0.17% 108
2022
Q1
$4.11M Buy
14,348
+313
+2% +$80.6K 0.33% 87
2021
Q4
$3.88M Buy
14,035
+2,040
+17% +$517K 0.28% 97
2021
Q3
$2.77M Buy
11,995
+6,118
+104% +$1.51M 0.2% 109
2021
Q2
$1.35M Sell
5,877
-1,329
-18% -$267K 0.15% 131
2021
Q1
$1.35M Buy
7,206
+4,851
+206% +$949K 0.19% 122
2020
Q4
$398K Sell
2,355
-633
-21% -$94.5K 0.06% 165
2020
Q3
$442K Buy
2,988
+176
+6% +$27.2K 0.09% 143
2020
Q2
$462K Hold
2,812
0.09% 141
2020
Q1
$390K Sell
2,812
-904
-24% -$124K 0.1% 136
2019
Q4
$488K Buy
3,716
+250
+7% +$29K 0.06% 152
2019
Q3
$388K Sell
3,466
-200
-5% -$22.3K 0.04% 167
2019
Q2
$406K Sell
3,666
-64
-2% -$7.54K 0.04% 164
2019
Q1
$484K Hold
3,730
0.05% 167
2018
Q4
$432K Buy
3,730
+50
+1% +$5.58K 0.05% 173
2018
Q3
$395K Sell
3,680
-1,250
-25% -$125K 0.03% 200
2018
Q2
$421K Sell
4,930
-608
-11% -$49.9K 0.03% 194
2018
Q1
$428K Sell
5,538
-8,300
-60% -$668K 0.03% 191
2017
Q4
$1.17M Sell
13,838
-800
-5% -$68.1K 0.09% 138
2017
Q3
$1.25M Sell
14,638
-1,875
-11% -$154K 0.08% 153
2017
Q2
$1.36M Sell
16,513
-2,750
-14% -$224K 0.08% 153
2017
Q1
$1.62M Buy
19,263
+1,850
+11% +$148K 0.08% 140
2016
Q4
$1.28M Buy
17,413
+1,784
+11% +$133K 0.06% 160
2016
Q3
$1.25M Buy
15,629
+3,924
+34% +$314K 0.06% 150
2016
Q2
$922K Sell
11,705
-696
-6% -$52.4K 0.04% 164
2016
Q1
$893K Sell
12,401
-1,136
-8% -$86K 0.04% 173
2015
Q4
$1.14M Buy
13,537
+7,434
+122% +$617K 0.05% 161
2015
Q3
$511K Buy
+6,103
New +$515K 0.02% 211
2015
Q2
Sell
-2,965
Closed -$215K 305
2015
Q1
$215K Sell
2,965
-38
-1% -$2.71K 0.01% 278
2014
Q4
$207K Sell
3,003
-200
-6% -$13.5K 0.01% 278
2014
Q3
$208K Buy
+3,203
New +$203K 0.01% 270
2013
Q4
Sell
-13,100
Closed -$659K 247
2013
Q3
$659K Hold
13,100
0.06% 152
2013
Q2
$643K Buy
+13,100
New +$713K 0.07% 150

Other funds holding LLY

Hodges Capital Management's LLY Position: Q1 2026 in Review

Hodges Capital Management reduced its Eli Lilly (LLY) stake by 0.49% in Q1 2026, selling an estimated $42.6K and leaving 8,613 shares worth $7.92M. The position accounts for 0.66% of the portfolio, ranked #55.

Hodges Capital Management first reported a position in LLY in Q2 2013 and has held it in 47 quarters since. The position peaked at $9.3M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Hodges Capital Management held 8,613 shares of Eli Lilly worth $7.92M as of Q1 2026.
  • Hodges Capital Management sold 42 Eli Lilly shares in Q1 2026, an estimated $42.6K.
  • Eli Lilly made up 0.66% of Hodges Capital Management's portfolio in Q1 2026, its #55 holding.
  • Hodges Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 47 quarters since.
  • Hodges Capital Management's Eli Lilly position peaked at $9.3M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hodges Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.